NasdaqCM:LQDAPharmaceuticals
Is It Too Late To Consider Liquidia (LQDA) After A 186% One Year Surge?
Wondering if Liquidia at around US$38.55 still offers value, or if most of the opportunity is already priced in? This article focuses squarely on what the current share price might mean for you as an investor.
Over the past year, Liquidia has delivered a 186.2% return, with gains of 22.8% year to date and 2.3% over the last week, while the 30 day return sits around 0%.
Recent headlines around Liquidia have centered on the company and its place in the pharmaceuticals space, with investors...